Umbilical cord‑derived mesenchymal stem cells (UC‑MSCs) are ethically sourced from Wharton’s Jelly and offer robust regenerative and immunomodulatory effects with minimal rejection risk. Their youthful biology makes them highly promising across treatments—from inflammatory conditions and aging to metabolic disorders.